Online citations, reference lists, and bibliographies.
← Back to Search

IL-17 In Atopic Eczema: Linking Allergen-specific Adaptive And Microbial-triggered Innate Immune Response.

K. Eyerich, D. Pennino, C. Scarponi, S. Foerster, F. Nasorri, H. Behrendt, J. Ring, C. Traidl‐Hoffmann, C. Albanesi, A. Cavani
Published 2009 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
BACKGROUND Patients with atopic eczema (AE) regularly experience colonization with Staphylococcus aureus that is directly correlated with the severity of eczema. Recent studies show that an impaired IL-17 immune response results in diseases associated with chronic skin infections. OBJECTIVE We sought to elucidate the effect of IL-17 on antimicrobial immune responses in AE skin. METHODS T cells infiltrating atopy patch test (APT) reactions were characterized for IL-17 secretion to varying stimuli. IL-17-dependent induction of the antimicrobial peptide human beta-defensin 2 (HBD-2) in keratinocytes was investigated. RESULTS Approximately 10% of APT-infiltrating T cells secreted IL-17 after phorbol 12-myristate 13-acetate (PMA)/ionomycin stimulation. Among these, 33% belonged to the newly characterized subtype T(H)2/IL-17. Despite the capacity to secrete IL-17, specific T-cell clones released only low amounts of IL-17 on cognate allergen stimulation, whereas IL-4, IFN-gamma, or both were efficiently induced. IL-17 secretion was not enhanced by IL-23, IL-1 beta, or IL-6 but was enhanced by the S aureus-derived superantigen staphylococcal enterotoxin B. Both healthy and AE keratinocytes upregulated HBD-2 in response to IL-17, but coexpressed IL-4/IL-13 partially inhibited this effect. In vivo, additional application of staphylococcal enterotoxin B induced IL-17 in APT reactions, whereas IL-4, IFN-gamma, and IL-10 were marginally regulated. Induced IL-17 upregulated HBD-2 in human keratinocytes in vivo. CONCLUSION IL-17-capable T cells, in particular T(H)2/IL-17 cells, infiltrate acute AE reactions. Although IL-17 secretion by specific T cells is tightly regulated, it can be triggered by bacteria-derived superantigens. The ineffective IL-17-dependent upregulation of HBD-2 in patients with AE is due to a partial inhibition by the type 2 microenvironment, which could partially explain why patients with AE do not clear S aureus.
This paper references
10.1073/PNAS.86.22.8941
Interaction of Staphylococcus aureus toxin "superantigens" with human T cells.
Y. Choi (1989)
10.1084/JEM.179.4.1109
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha
F. Sallusto (1994)
10.1111/1523-1747.EP12321078
Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients.
M. Grewe (1995)
10.1159/000237609
The 'atopy patch test' in evaluating the role of aeroallergens in atopic eczema.
J. Ring (1997)
10.1126/SCIENCE.286.5439.525
Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.
D. Yang (1999)
10.1067/MAI.2000.105528
Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis.
R. Bunikowski (2000)
10.1046/j.1365-2230.2000.00695.x
Airborne and dietary allergens in atopic eczema: a comprehensive review of diagnostic tests
U. Darsow (2000)
10.1046/J.1523-1747.2000.00041.X
Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes.
C. Albanesi (2000)
10.1046/J.1523-1747.2000.00881.X
Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses.
A. Cavani (2000)
10.1056/NEJMRA020100
The effect of infections on susceptibility to autoimmune and allergic diseases.
J. Bach (2002)
10.1056/NEJMOA021481
Endogenous antimicrobial peptides and skin infections in atopic dermatitis.
P. Ong (2002)
10.1067/MAI.2003.1414
Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions.
M. Toda (2003)
10.1007/s10096-003-0928-0
High Prevalence of Superantigens Associated with the egc Locus in Staphylococcus aureus Isolates from Patients with Atopic Eczema
M. Mempel (2003)
10.1128/IAI.71.7.3730-3739.2003
Staphylococcus aureus Susceptibility to Innate Antimicrobial Peptides, β-Defensins and CAP18, Expressed by Human Keratinocytes
K. Midorikawa (2003)
10.1172/JCI21060
New insights into atopic dermatitis.
D. Leung (2004)
10.1111/j.1365-2222.2004.01841.x
Trends in asthma, allergic rhinitis and eczema among Swedish conscripts from farming and non‐farming environments. A nationwide study over three decades
L. Bråbäck (2004)
10.1038/ng1767
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis
C. Palmer (2006)
10.1084/jem.20061308
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides
Spencer C. Liang (2006)
10.1016/J.CLIM.2006.08.008
Mechanism of HBD-3 deficiency in atopic dermatitis.
M. Howell (2006)
10.1172/JCI25308
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.
Yi Chen (2006)
10.1084/jem.20070663
Phenotypic and functional features of human Th17 cells
F. Annunziato (2007)
10.1073/pnas.0700733104
Bacterial superantigen facilitates epithelial presentation of allergen to T helper 2 cells
M. Ardern-Jones (2007)
10.1038/ni0407-345
TH-17 cells in the circle of immunity and autoimmunity
E. Bettelli (2007)
10.1038/ni0907-903
TH-17 differentiation: of mice and men
Arian D J Laurence (2007)
10.1038/ni1496
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells
Eva Acosta-Rodriguez (2007)
10.1038/ni1467
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Eva Acosta-Rodriguez (2007)
10.1111/j.1600-0625.2006.00523.x
Staphylococcus aureus‐derived enterotoxins enhance house dust mite‐induced patch test reactions in atopic dermatitis
K. Langer (2007)
10.1159/000109290
Pollen Grains Induce a Rapid and Biphasic Eczematous Immune Response in Atopic Eczema Patients
K. Eyerich (2007)
10.4049/jimmunol.179.2.984
IL-4 and IL-13 Negatively Regulate TNF-α- and IFN-γ-Induced β-Defensin Expression through STAT-6, Suppressor of Cytokine Signaling (SOCS)-1, and SOCS-31
C. Albanesi (2007)
10.1038/nature06764
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
J. Milner (2008)
10.1038/jid.2008.139
Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.
K. Eyerich (2008)
10.1016/j.jaci.2008.02.014
Filaggrin mutations, atopic eczema, hay fever, and asthma in children.
S. Weidinger (2008)



This paper is referenced by
10.1111/joim.13235
So close, and yet so far away: The dichotomy of the specific immune response and inflammation in psoriasis and atopic dermatitis
A. Schäbitz (2021)
10.3390/ijms22147527
Diagnostic Tools and Biomarkers for Severe Drug Eruptions
M. Yoshioka (2021)
10.3389/fmed.2021.665647
Recent Updates on the Involvement of PI3K/AKT/mTOR Molecular Cascade in the Pathogenesis of Hyperproliferative Skin Disorders
L. Mercurio (2021)
10.5772/INTECHOPEN.97287
Atopic Dermatitis in Adults: Epidemiology, Risk Factors, Pathogenesis, Clinical Features, and Management
Olumayowa Abimbola Oninla (2021)
10.5114/ada.2019.88394
Cytokines and apoptosis in atopic dermatitis
£ukasz Szymański (2021)
10.3390/jpm11060494
Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
C. Scheau (2021)
10.3390/ijms22115794
The Role of IL-17-Producing Cells in Cutaneous Fungal Infections
Y. Sawada (2021)
10.3390/ijms21041314
The Role of Th17-Related Cytokines in Atopic Dermatitis
M. Sugaya (2020)
10.1111/all.14557
Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins
F. Lauffer (2020)
10.1002/kjm2.12163
Subcutaneous injection of recombinant heat shock protein 70 ameliorates atopic dermatitis skin lesions in a mouse model
Jun-Kai Kao (2020)
10.1111/jdv.17009
Developments and challenges in dermatology: an update from the Interactive Derma Academy (IDeA) 2019
T. Luger (2020)
10.34172/aim.2020.71
Beneficial Effects of Adding Topical Atorvastatin 5% Cream to Topical Betamethasone 1% Ointment on Chronic Hand Eczema.
M. Mehrpooya (2020)
10.1111/imr.12913
γδ T cells and inflammatory skin diseases
M. H. Jee (2020)
10.1007/978-3-030-19922-7_5
Inflammation of the Skin and Its Therapeutic Targets
C. Mathias (2019)
10.1159/000497383
Atopic Dermatitis: Collegium Internationale Allergologicum (CIA) Update 2019
D. Simon (2019)
10.3390/ijms20174070
Antagonistic Effects of IL-4 on IL-17A-Mediated Enhancement of Epidermal Tight Junction Function
Matthew G Brewer (2019)
10.1111/bjd.18643
The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group
H. Alexander (2019)
10.17169/refubium-25660
Identification and characterization of murine and human Th2/1 hybrid cells in Th2-driven diseases
Cristin N. Bock (2019)
10.1101/827899
IL-17A both initiates (via IFNγ suppression) and limits the pulmonary type-2 immune response to nematode infection
J. Ajendra (2019)
10.1038/s41598-019-47769-2
Human thioredoxin, a damage-associated molecular pattern and Malassezia-crossreactive autoallergen, modulates immune responses via the C-type lectin receptors Dectin-1 and Dectin-2
L. M. Roesner (2019)
10.1016/j.jaci.2018.10.033
Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council
K. Eyerich (2019)
10.1111/cea.13289
Staphylococcus aureus‐derived extracellular vesicles induce monocyte recruitment by activating human dermal microvascular endothelial cells in vitro
J. Kim (2019)
10.1111/jdv.16094
Inflammatory alopecia in patients on dupilumab: a retrospective cohort study at an academic institution
G.A. Zhu (2019)
10.1007/s00105-019-4424-6
Atopisches Ekzem und Mikrobiom
M. Reiger (2019)
10.1016/j.jaci.2019.01.015
Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis.
L. Zhou (2019)
Regulatory mechanisms underlying atopic dermatitis: Functional characterization of the C11orf30/LRRC32 locus and analysis of genome-wide expression profiles in patients
Judith Manz (2018)
10.1111/bjd.16734
Epithelial barrier dysfunctions in atopic dermatitis: a skin–gut–lung model linking microbiome alteration and immune dysregulation
T. Zhu (2018)
10.1111/jdv.14673
Immune response patterns in non‐communicable inflammatory skin diseases
K. Eyerich (2018)
10.1007/978-1-4939-7534-1_2
Microbiome: Allergic Diseases of Childhood
O. Aktaş (2018)
10.3892/ol.2018.9316
Recruitment and significance of Th22 cells and Th17 cells in malignant ascites.
X. Yang (2018)
10.1016/j.vetimm.2018.11.009
A canine keratinocyte cell line expresses antimicrobial peptide and cytokine genes upon stimulation with bacteria, microbial ligands and recombinant cytokines.
Suttiwee Chermprapai (2018)
10.1007/s00105-018-4127-4
[Pathogenesis of atopic dermatitis].
C. Scheerer (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar